These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 7531020)
1. Electric treatment of human melanoma skin lesions with low level direct electric current: an assessment of clinical experience following a preliminary study in five patients. Plesnicar A; Sersa G; Vodovnik L; Jancar J; Zaletel-Kragelj L; Plesnicar S Eur J Surg Suppl; 1994; (574):45-9. PubMed ID: 7531020 [TBL] [Abstract][Full Text] [Related]
2. Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients. Sersa G; Stabuc B; Cemazar M; Miklavcic D; Rudolf Z Clin Cancer Res; 2000 Mar; 6(3):863-7. PubMed ID: 10741708 [TBL] [Abstract][Full Text] [Related]
3. Clinical and experimental studies of anti-tumoural effects of electrochemical therapy (ECT) alone or in combination with chemotherapy. Matsushima Y; Takahashi E; Hagiwara K; Konaka C; Miura H; Kato H; Koshiishi Y Eur J Surg Suppl; 1994; (574):59-67. PubMed ID: 7531023 [TBL] [Abstract][Full Text] [Related]
4. A pilot study with very low-intensity, intermediate-frequency electric fields in patients with locally advanced and/or metastatic solid tumors. Salzberg M; Kirson E; Palti Y; Rochlitz C Onkologie; 2008 Jul; 31(7):362-5. PubMed ID: 18596382 [TBL] [Abstract][Full Text] [Related]
5. [Direct current therapy (DCT) for malignant tumors]. Xin YL Zhonghua Zhong Liu Za Zhi; 1992 Nov; 13(6):467-9. PubMed ID: 1576916 [TBL] [Abstract][Full Text] [Related]
6. Bleomycin-mediated electrochemotherapy of metastatic melanoma. Glass LF; Pepine ML; Fenske NA; Jaroszeski M; Reintgen DS; Heller R Arch Dermatol; 1996 Nov; 132(11):1353-7. PubMed ID: 8915314 [TBL] [Abstract][Full Text] [Related]
7. A pilot study of human interferon beta gene therapy for patients with advanced melanoma by in vivo transduction using cationic liposomes. Matsumoto K; Kubo H; Murata H; Uhara H; Takata M; Shibata S; Yasue S; Sakakibara A; Tomita Y; Kageshita T; Kawakami Y; Mizuno M; Yoshida J; Saida T Jpn J Clin Oncol; 2008 Dec; 38(12):849-56. PubMed ID: 18945721 [TBL] [Abstract][Full Text] [Related]
8. Bolus high dose interleukin-2 for the treatment of malignant melanoma. Pappo I; Lotem M; Klein M; Orda R Isr Med Assoc J; 2001 Mar; 3(3):169-73. PubMed ID: 11303372 [TBL] [Abstract][Full Text] [Related]
9. Organ- and treatment-specific local response rates to systemic and local treatment modalities in stage IV melanoma. Richtig E; Ludwig R; Kerl H; Smolle J Br J Dermatol; 2005 Nov; 153(5):925-31. PubMed ID: 16225601 [TBL] [Abstract][Full Text] [Related]
10. Dendritic cell immunotherapy for stage IV melanoma. O'Rourke MG; Johnson MK; Lanagan CM; See JL; O'Connor LE; Slater GJ; Thomas D; Lopez JA; Martinez NR; Ellem KA; Schmidt CW Melanoma Res; 2007 Oct; 17(5):316-22. PubMed ID: 17885587 [TBL] [Abstract][Full Text] [Related]
11. Dendritoma vaccination combined with low dose interleukin-2 in metastatic melanoma patients induced immunological and clinical responses. Wei Y; Sticca RP; Holmes LM; Burgin KE; Li J; Williamson J; Evans L; Smith SJ; Stephenson JJ; Wagner TE Int J Oncol; 2006 Mar; 28(3):585-93. PubMed ID: 16465362 [TBL] [Abstract][Full Text] [Related]
12. [Regression of over 150 skin metastases of malignant melanoma with complex homeopathic therapy]. Ehring F Hautarzt; 1989 Jan; 40(1):23-7. PubMed ID: 2921115 [TBL] [Abstract][Full Text] [Related]
13. Preliminary experiences of intralesional immunotherapy in cutaneous metastatic melanoma. Ridolfi L; Ridolfi R Hepatogastroenterology; 2002; 49(44):335-9. PubMed ID: 11995445 [TBL] [Abstract][Full Text] [Related]
14. Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma. Eton O; Kharkevitch DD; Gianan MA; Ross MI; Itoh K; Pride MW; Donawho C; Buzaid AC; Mansfield PF; Lee JE; Legha SS; Plager C; Papadopoulos NE; Bedikian AY; Benjamin RS; Balch CM Clin Cancer Res; 1998 Mar; 4(3):619-27. PubMed ID: 9533529 [TBL] [Abstract][Full Text] [Related]
15. Comparison of S100 protein and MIA protein as serum marker for malignant melanoma. Djukanovic D; Hofmann U; Sucker A; Rittgen W; Schadendorf D Anticancer Res; 2000; 20(3B):2203-7. PubMed ID: 10928178 [TBL] [Abstract][Full Text] [Related]
16. Prolonged survival of 2 years or longer for patients with disseminated melanoma. An analysis of related prognostic factors. Brand CU; Ellwanger U; Stroebel W; Meier F; Schlagenhauff B; Rassner G; Garbe C Cancer; 1997 Jun; 79(12):2345-53. PubMed ID: 9191522 [TBL] [Abstract][Full Text] [Related]
17. [Tolerance and feasibility of adjuvant treatment of stage II malignant melanoma with high-dose interferon-alpha]. Bédane C; Le Brun V; Boulinguez S; Berdah JF; Bouyssou ML; Delpuget N; Bernard P; Tubiana-Mathieu N; Bonnetblanc JM Ann Dermatol Venereol; 1999 Feb; 126(2):142-6. PubMed ID: 10352829 [TBL] [Abstract][Full Text] [Related]
18. Pilot study of high-dose, concurrent biochemotherapy for advanced melanoma. Kim KB; Eton O; East MJ; Hodges C; Papadopoulos NE; Grimm EA; Bedikian AY Cancer; 2004 Aug; 101(3):596-603. PubMed ID: 15274073 [TBL] [Abstract][Full Text] [Related]
19. Prolonged untreated and treated course of a malignant melanoma. Nashan D; Haufs MG; Kleinheinz J; Al-Dandashi C; Bruckner-Tuderman L Dermatology; 2006; 212(1):93-5. PubMed ID: 16319486 [No Abstract] [Full Text] [Related]
20. Metastatic melanoma in the eye and orbit. Zografos L; Ducrey N; Beati D; Schalenbourg A; Spahn B; Balmer A; Othenin-Girard CB; Chamot L; Egger E Ophthalmology; 2003 Nov; 110(11):2245-56. PubMed ID: 14597536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]